SERPINA1 and alpha 1-antitrypsin deficiency: In the clinical trial for alpha-1-antitrypsin (AAT) deficiency, intramuscular gene delivery produced similar AAT levels in two subjects with pre-existing NAB titers of 1:80 and 1:160 against AAV1 vectors; these results are similar to those of individuals testing as seronegative [48].